A clinical study, using single-cell RNA sequencing of biopsy specimens from EGFR-mutant NSCLC, showed that macrophage infiltration decreased with EGFR-TKI treatment, to which the tumor was sensitive and increased in resistant cases. The gene discussed is EGFR; the disease is neoplasm.